-DOCSTART- -X- O
We -X- _ O
have -X- _ O
developed -X- _ O
a -X- _ O
simple -X- _ O
electrochemical -X- _ O
biosensing -X- _ O
strategy -X- _ O
for -X- _ O
the -X- _ O
label-free -X- _ O
diagnosis -X- _ O
of -X- _ O
hepatitis -X- _ B-Patient
B -X- _ I-Patient
virus -X- _ I-Patient
( -X- _ I-Patient
HBV -X- _ I-Patient
) -X- _ I-Patient
on -X- _ O
a -X- _ O
gold -X- _ O
electrode -X- _ O
surface. -X- _ O
Gold-binding -X- _ B-Intervention
polypeptide -X- _ I-Intervention
( -X- _ I-Intervention
GBP -X- _ I-Intervention
) -X- _ I-Intervention
fused -X- _ I-Intervention
with -X- _ I-Intervention
single-chain -X- _ I-Intervention
antibody -X- _ I-Intervention
( -X- _ I-Intervention
ScFv -X- _ I-Intervention
) -X- _ I-Intervention
against -X- _ I-Intervention
HBV -X- _ I-Intervention
surface -X- _ I-Intervention
antigen -X- _ I-Intervention
( -X- _ I-Intervention
HBsAg -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ O
in -X- _ O
forms -X- _ O
of -X- _ O
genetically -X- _ O
engineered -X- _ O
protein -X- _ O
, -X- _ O
was -X- _ O
utilized. -X- _ O
This -X- _ O
GBP-ScFv -X- _ B-Intervention
fusion -X- _ I-Intervention
protein -X- _ I-Intervention
can -X- _ O
directly -X- _ B-Outcome
bind -X- _ I-Outcome
onto -X- _ I-Outcome
the -X- _ I-Outcome
gold -X- _ I-Outcome
substrate -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
strong -X- _ I-Outcome
binding -X- _ I-Outcome
affinity -X- _ I-Outcome
between -X- _ I-Outcome
the -X- _ I-Outcome
GBP -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
gold -X- _ I-Outcome
surface -X- _ I-Outcome
, -X- _ I-Outcome
while -X- _ I-Outcome
the -X- _ I-Outcome
recognition -X- _ I-Outcome
site -X- _ I-Outcome
orients -X- _ I-Outcome
toward -X- _ I-Outcome
the -X- _ I-Outcome
sample -X- _ I-Outcome
for -X- _ I-Outcome
target -X- _ I-Outcome
binding -X- _ I-Outcome
at -X- _ I-Outcome
the -X- _ I-Outcome
same -X- _ I-Outcome
time. -X- _ I-Outcome
Furthermore -X- _ O
, -X- _ O
this -X- _ O
one-step -X- _ O
immobilization -X- _ O
strategy -X- _ O
greatly -X- _ O
simplifies -X- _ O
a -X- _ O
fabrication -X- _ O
process -X- _ O
without -X- _ O
any -X- _ O
chemical -X- _ O
modification -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
maintaining -X- _ O
activity -X- _ O
of -X- _ O
biological -X- _ O
recognition -X- _ O
elements. -X- _ O
This -X- _ O
system -X- _ O
allows -X- _ B-Outcome
specific -X- _ I-Outcome
immobilization -X- _ I-Outcome
of -X- _ I-Outcome
proteins -X- _ I-Outcome
and -X- _ I-Outcome
sensitive -X- _ I-Outcome
detection -X- _ I-Outcome
of -X- _ I-Outcome
targets -X- _ I-Outcome
, -X- _ O
which -X- _ O
were -X- _ O
verified -X- _ O
by -X- _ O
surface -X- _ O
plasmon -X- _ O
resonance -X- _ O
analysis -X- _ O
and -X- _ O
successfully -X- _ O
applied -X- _ O
to -X- _ O
electrochemical -X- _ O
cyclic -X- _ O
voltammetry -X- _ O
and -X- _ O
impedance -X- _ O
spectroscopy -X- _ O
upto -X- _ O
0.14 -X- _ O
ng -X- _ O
/ -X- _ O
mL -X- _ O
HBsAg -X- _ O
. -X- _ O

